FailedFiled Nov 21, 2025
Sponsor: Bill Gannon (R)
Latest Action
Inexpedient to Legislate: MA VV 04/23/2026 HJ 11 P. 55
Apr 23, 2026
Summary
The bill sought to reclassify xylazine as a Schedule III controlled drug in New Hampshire, changing its legal status. This would affect anyone possessing, distributing, or prescribing the substance by subjecting it to Schedule III regulations. The measure was rejected as “inexpedient to legislate.”
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Track this bill
Get real-time alerts when SB 465 changes status, plus AI-powered summaries and stage predictions.
Sign up free